Danaher (DHR) Non-Current Assets (2009 - 2026)
Danaher (DHR) posted Non-Current Assets of $79.0 billion for Q2 2026, up 13.47% on a QoQ basis from $69.6 billion in Q1 2026, and up 11.84% year-over-year from $70.6 billion in Q2 2025.
Analysis
Danaher (DHR) Non-Current Assets (2009 - 2026) Analysis & Trends
Danaher has reported Non-Current Assets for 18 years, with the latest figure at $79.0 billion in Q2 2026.
- On a quarterly basis, Non-Current Assets rose 11.84% year-over-year to $79.0 billion in Q2 2026; TTM through Jun 2026 was $289.6 billion, a 3.87% increase from a year earlier, with the FY2025 full-year figure at $70.7 billion, up 3.91% from the prior year.
- Non-Current Assets was $79.0 billion for Q2 2026 at Danaher, up from $69.6 billion in the prior quarter.
- The five-year high for Non-Current Assets was $79.0 billion in Q2 2026, with the low at $66.5 billion in Q3 2023.
- Average Non-Current Assets over 5 years is $69.7 billion, with a median of $69.3 billion recorded in 2024.
- The largest YoY upside for Non-Current Assets was 15.16% in 2022 against a maximum downside of 6.89% in 2022.
- Over 5 years, Non-Current Assets stood at $68.5 billion in 2022, then grew by 3.04% to $70.6 billion in 2023, then fell by 3.55% to $68.0 billion in 2024, then increased by 3.91% to $70.7 billion in 2025, then climbed by 11.71% to $79.0 billion in 2026.
- The last three Non-Current Assets figures came in at $79.0 billion (Q2 2026), $69.6 billion (Q1 2026), and $70.7 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 89.81 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 78.99 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 9.27 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 3.82 Bn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 9.75 Bn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 1.84 Bn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 7.23 Bn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 1.75 Bn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 355.40 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 3.83 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 26, 2026 | 78.99 Bn |
| Mar 27, 2026 | 69.61 Bn |
| Dec 31, 2025 | 70.71 Bn |
| Sep 26, 2025 | 70.29 Bn |
| Jun 27, 2025 | 70.62 Bn |
| Mar 28, 2025 | 69.59 Bn |
| Dec 31, 2024 | 68.05 Bn |
| Sep 27, 2024 | 70.56 Bn |
| Jun 28, 2024 | 68.95 Bn |
| Mar 29, 2024 | 69.03 Bn |
| Dec 31, 2023 | 70.55 Bn |
| Sep 29, 2023 | 66.53 Bn |
| Jun 30, 2023 | 67.44 Bn |
| Mar 31, 2023 | 68.51 Bn |
| Dec 31, 2022 | 68.47 Bn |
| Sep 30, 2022 | 66.78 Bn |
| Jul 1, 2022 | 68.58 Bn |
| Apr 1, 2022 | 70.72 Bn |
| Dec 31, 2021 | 71.54 Bn |
| Oct 1, 2021 | 71.72 Bn |